![Raidy Kevin J.](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Raidy Kevin J.
Directeur/Membre du Conseil chez
Escient Pharmaceuticals, Inc.
Profil
Raidy Kevin J. is the founder of Shipley Raidy Capital Partners.
Current positions include Director at Escient Pharmaceuticals, Inc. since 2020, Director at NodThera Ltd., Director at Aro Biotherapeutics Co., Director at Neuron23, Inc., Senior Managing Director at Blue Owl Healthcare Opportunities Advisors LLC since 2017, and Managing Partner at Cowen Investment Management LLC.
Former roles include Director & Venture Partner at Personal Genome Diagnostics, Inc., Director at Semma Therapeutics, Inc., Independent Director at Pliant Therapeutics, Inc., Director at Oncorus, Inc., Independent Director at Repare Therapeutics, Inc. from 2019 to 2020, Director at Orchard Therapeutics Plc, Senior Managing Director at Blue Owl Capital, Inc., Managing Partner at Cowen & Co. LLC in 2019, Principal at Cantor Fitzgerald & Co., and Analyst at Ramius Securities LLC.
Education includes undergraduate studies at The Wharton School of the University of Pennsylvania.
Postes actifs de Raidy Kevin J.
| Sociétés | Poste | Début |
|---|---|---|
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Directeur/Membre du Conseil | 14/09/2020 |
Aro Biotherapeutics Co.
 Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Directeur/Membre du Conseil | - |
Neuron23, Inc.
 Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Directeur/Membre du Conseil | - |
NodThera Ltd.
 NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Directeur/Membre du Conseil | - |
Cowen Investment Management LLC
 Cowen Investment Management LLC Investment ManagersFinance Cowen Investment Management invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical and healthcare services. It provides financing for early and late stage capital requirements. Cowen Investment Management reorganized its healthcare operating segments on December 1, 2023, by combining Cowen Healthcare Investments into a single segment called Blue Owl Healthcare Opportunities Advisors LLC. | Private Equity Investor | - |
Anciens postes connus de Raidy Kevin J.
| Sociétés | Poste | Fin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Directeur/Membre du Conseil | 18/06/2020 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/04/2019 |
Ramius Securities LLC
 Ramius Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 31/05/2010 |
| BLUE OWL CAPITAL INC. | Corporate Officer/Principal | - |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Raidy Kevin J.
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
99
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cantor Fitzgerald & Co.
 Cantor Fitzgerald & Co. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cowen Investment Management LLC
Cowen Investment Management LLC Investment ManagersFinance Cowen Investment Management invests in companies located in the United States. The firm targets companies operating in the fields of biopharmaceutical and healthcare services. It provides financing for early and late stage capital requirements. Cowen Investment Management reorganized its healthcare operating segments on December 1, 2023, by combining Cowen Healthcare Investments into a single segment called Blue Owl Healthcare Opportunities Advisors LLC. | Finance |
Personal Genome Diagnostics, Inc.
 Personal Genome Diagnostics, Inc. BiotechnologyHealth Technology Provides cancer genome analysis to help researchers identify cancer-related genetic changes | Health Technology |
Shipley Raidy Capital Partners | |
Ramius Securities LLC
Ramius Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Oncorus, Inc.
 Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
Repare Therapeutics, Inc.
 Repare Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery and development of novel cancer therapies | Health Technology |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
NodThera Ltd.
NodThera Ltd. BiotechnologyHealth Technology Operates biotechnology company which discovers and develops new treatments for diseases driven by chronic inflammation | Health Technology |
Orchard Therapeutics Plc
 Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases | Health Technology |
Aro Biotherapeutics Co.
Aro Biotherapeutics Co. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on the research and development of a new generation of protein biologics | Health Technology |
Neuron23, Inc.
Neuron23, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that focuses on developing precision medicines for genetically defined neurological and immunological diseases | Commercial Services |
Blue Owl Capital, Inc.
 Blue Owl Capital, Inc. Investment ManagersFinance Operates as an alternative asset management firm | Finance |
Choisissez Zonebourse 
